Hybrid Event: 36^th Annual Meeting & Pre-Conference Programs

November 10-14, 2021 • Washington, D.C. • Join us in person or virtually

Join SITC in Washington, D.C., or virtually, Nov. 10-14, 2021, to take part in the leading destination for scientific exchange, education and networking in the cancer immunotherapy field. 

REgister LEARN MORE

Annual Meeting & Pre-Conference Programs

The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brought together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy.

Cancer Immune Responsiveness Workshop

Cancer Immune Responsiveness Task force hosted a two-day workshop in 2018 and 2019 which focused on the advancement of interactions between the immune system and cancer that contribute to immunotherapy response and resistance.

SITC Cancer Immunotherapy Winter School

The Cancer Immunotherapy Winter School curriculum covers the fundamentals of cancer immunotherapy.

• Cytokine-based Immunotherapies and Other Molecular Bispecifics, Other Immunotherapies
• Immunotherapeutic Strategy: Can Cancer Vaccines Really Work?

VIEW all 2020 Program materials

• Cytokine-based Immunotherapies and Other Molecular Bispecifics, Other Immunotherapies
• Immunotherapeutic Strategy: Can Cancer Vaccines Really Work?

VIEW all 2019 Program materials

Journal for Immunotherapy of Cancer

The Journal for ImmunoTherapy of Cancer, the official journal of the Society for Immunotherapy of Cancer (SITC), is an open access, peer-reviewed journal with a 2020 impact factor of 13.751.

SITC Consensus Statements, Guidelines and White Papers

• Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
• The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
• Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
• An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0
• Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia
• Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma 
• The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
• The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
• Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma

• The Society for Immunotherapy of Cancer perspective on regulation of interleukin 6 signaling in COVID-19-related systemic inflammatory response
• Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

Textbook

Cancer Immunotherapy Principles and Practice is an authoritative textbook to cancer immunobiology and the immunotherapy treatments that harness the immune system to combat malignant disease. This comprehensive reference work covers all major topics that have shaped the development of immunotherapy and propelled it to its current place at the forefront of cancer treatment innovation.

Section 2: Cancer Immunotherapy Targets and Classes

• Chapter 17: Cancer Vaccines: Considerations of Antigen, Formulation, and Deliver
• Chapter 18: T Cell Modulatory Cytokines
• Chapter 21: Agonistic Antibodies to Co-Stimulatory Molecules
• Chapter 22: Immune Effects of Conventional Cancer Therapeutics
• Chapter 23: Oncolytic Viruses
• Chapter 24: Principles of Combination Immunotherapies

PURCHASE THE TEXTBOOK

Society for Immunotherapy of Cancer (SITC) offers a variety of online educational activities, resources and continuing education opportunities on cancer immunotherapy.

There are no courses or webinars available at this time for cytokines, vaccines, viruses and novel therapies. To check out other online courses, click the button below.

EXPLORE ALL ONLINE OFFERINGS